# DNAlite Therapeutics, Inc. — Form D

DNAlite Therapeutics, Inc. of SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2022-04-15. The offering totals $8.9M, of which $5.6M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2022-04-15
- Form: D
- Accession: 0001922565-22-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $8.9M
- Amount sold: $5.6M
- Remaining: $3.3M
- Investors: 18
- Date of first sale: 2022-04-01
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-441983

## Issuer

- Name: DNAlite Therapeutics, Inc.
- CIK: 0001922565
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 455 MISSION BAY BOULEVARD, SAN FRANCISCO, CA, 94158
- Phone: (713) 569-0302

## Officers, directors & promoters (6)

| Name | Role | Location |
| --- | --- | --- |
| Mubhij Ahmad | Director | San Francisco, CA |
| Timothy Paul Day | Director | San Francisco, CA |
| Drew Cain Lanza | Director | San Francisco, CA |
| Andrew Cain McClary | Director | San Francisco, CA |
| David Cain Rabuka | Director | San Francisco, CA |
| Mubhij Ahmad | Executive Officer | San Francisco, CA |

## More

- [CIK 1922565 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1922565&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001922565-22-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.